Longduoduo Co

Longduoduo Co Forward P/E

The Forward P/E Ratio of Longduoduo Co (LDDD) as of Oct 31, 2026 is -26.46. In the previous year, Forward P/E Ratio was 33.25 — a change of -179.57% (lower).

Forward P/E

-26.46

YoY

-179.57%

Last updated:

Forward P/E Ratio of Longduoduo Co is 2026 -26.46 . Forward P/E Ratio of Longduoduo Co was 2025 33.25 . It decreases by -179.57% lower compared to the previous year.

The Longduoduo Co Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2021
-46.59 USD
Jan 1, 2022
-2.04 USD
Jan 1, 2023
-391.67 USD
Jan 1, 2024
12.19 USD
Jan 1, 2025
33.25 USD
Jan 1, 2026
-26.46 USD
The Longduoduo Co Forward P/E history
YEARForward P/EYoY
-26.46-179.57%
33.25+172.67%
12.19-103.11%
-391.67+19,131.41%
-2.04-95.63%
-46.59—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Longduoduo Co Stock analysis

What does Longduoduo Co do? Longduoduo Co Ltd operates in the Health Care Providers & Services industry, focusing on preventive care for cardiovascular and cerebrovascular diseases such as myocardial infarction and cerebral infarction. The company collaborates with third-party healthcare service providers to offer preventive healthcare solutions, including health products and medical examinations. Its primary market is domestic, serving customers seeking preventive services for conditions like hemiplegia and cardiovascular diseases. The firm's revenue comes from providing these integrated preventive care services through its partnerships and domestic operations. Longduoduo Co Ltd generates income by delivering preventive healthcare solutions that combine health products with medical examinations and services. The company partners with third-party healthcare service providers to expand its service offerings, targeting individuals concerned about cardiovascular and cerebrovascular health risks. Domestic customers purchase these preventive care packages, which address specific health issues including myocardial infarction prevention and hemiplegia management. The business model relies on domestic market sales of these integrated health solutions. The company's revenue streams are derived from domestic sales of preventive healthcare services, including health products and medical examinations provided through third-party partnerships. Longduoduo focuses on cardiovascular and cerebrovascular disease prevention, targeting customers interested in avoiding conditions like myocardial infarction and cerebral infarction. Its services are designed to address specific health concerns such as hemiplegia, with the firm operating exclusively within the domestic market to deliver these preventive care solutions. Longduoduo Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Longduoduo Co stock

Forward P/E Ratio of Longduoduo Co is -26.46 in 2026.

Forward P/E Ratio of Longduoduo Co changed from 33.25 to -26.46, representing a -179.57% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Longduoduo Co since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Longduoduo Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Longduoduo Co

All Key Metrics — Longduoduo Co